CORT · Company research
Corcept Therapeutics Inc. (CORT): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 119.6 | $14,029,806,350 | 13918767350.00 | 134.79299363057325 | — | 5.584281164695176 | — | 19.8785540313073836 | 452.35551668547477026591 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.